Immunoproteasome inhibitor DPLG3 attenuates experimental...

Biochemical Pharmacology 2020 / 07 Vol. 177

Immunoproteasome inhibitor DPLG3 attenuates experimental colitis by restraining NF-κB activation

Moallemian, Rezvan, Rehman, Ashfaq Ur., Zhao, Na, Wang, Huan, Chen, Haifeng, Lin, Gang, Ma, Xiaojing, Yu, Jing
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
177
Journal:
Biochemical Pharmacology
DOI:
10.1016/j.bcp.2020.113964
Date:
July, 2020
File:
PDF, 2.57 MB
2020
Conversion to is in progress
Conversion to is failed